The Singapore-based RV Healthcare PTE intends to implement a project designed to create production facilities in Uzbekistan.
This was announced during the recent talks between the first deputy chairman of the State Investments Committee Sunnatulla Bekenov and representatives of the Singaporean company.
In the first stage of the project, in 2018, it is planned to open a distribution center with the establishment of a trade enterprise with foreign investments and the range of more than 40 types of medicines, including auxiliary substances.
In the second phase of the project, in 2019-2020, the Singaporean partners intend to transfer technologies for the production and packaging of high-tech antiviral medicines (hepatitis B, C and antiretroviral drugs), oral anti-cancer drugs, injections and bio-stimulators. And finally, in the third part, in 2021-2022, it is projected to launch full-cycle production of pharmaceuticals.
It is worth noting that RV Healthcare PTE is one of the major pharmaceutical manufacturers in Asia. It has three manufacturing plants in India, two mills in Vietnam and Myanmar, and one enterprise each in mainland China and Hong Kong, Cambodia, the United Kingdom, Thailand, Kazakhstan and the Philippines.